Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease

被引:0
作者
Abu-Sbeih, Hamzah [1 ]
Faleck, David [2 ]
Ricciuti, Biagio [3 ]
Mendelsohn, Robin [4 ]
Naqash, Abdul Rafeh [5 ]
Cohen, Justine [6 ]
Sellars, MacLean [6 ]
Balaji, Aanika [7 ]
Ben-betzalel, Guy [8 ]
Hajir, Ibraheim [9 ]
Zhang, Jiajia [7 ]
Awad, Mark [3 ]
Leonardi, Giulia [3 ]
Johnson, Douglas [10 ]
Pinato, David [11 ]
Owen, Dwight [12 ]
Weiss, Sarah [13 ]
Lamberti, Giuseppe [14 ]
Lythgoe, Mark [11 ]
Manuzzi, Lisa [14 ]
Arnold, Christina [12 ]
Qiao, Wei [1 ]
Naidoo, Jarushka [7 ]
Markel, Gal [8 ]
Powell, Nick [9 ]
Yeung, Sai-Ching [1 ]
Sharon, Elad [15 ]
Dougan, Michael [6 ]
Wang, Yinghong [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mem Sloan Kattering Canc Ctr, New York, NY USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] East Carolina Univ, Greenville, NC 27858 USA
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
[7] Johns Hopkins Univ, Baltimore, MD USA
[8] Sheba Med Ctr, Ramat Gan, Israel
[9] Kings Coll London, London, England
[10] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[11] Imperial Coll London, London, England
[12] Ohio State Univ, Columbus, OH 43210 USA
[13] Yale Univ, New Haven, CT USA
[14] Bologna Univ, Brookline, MA USA
[15] NCI, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O64
引用
收藏
页数:2
相关论文
empty
未找到相关数据